🟢 Recursion Pharmaceuticals is trading 5.39% up today with no clear company-specific catalyst identified

Recursion Pharmaceuticals is trading $3.52, up 5.39%, with no clearly identified company-specific catalyst on August 21, 2026.

• No new company announcement or filing was identified during the session.
• Its latest major disclosure was the August 5 quarterly update, covering pipeline progress and lower expense guidance.
• The broader market is modestly higher, but biotech-sector context is weaker, leaving the immediate catalyst unclear.